肢带型肌营养不良症2B型与免疫介导的坏死性肌病临床及影像学差异分析

doi:10.3969/j.issn.1672-6731.2020.09.004

摘要/Abstract

摘要：

目的探讨肢带型肌营养不良症2B型（LGMD2B）与免疫介导的坏死性肌病（IMNM）的临床和影像学差异。方法纳入2014年1月至2018年12月收治的LGMD2B型（45例）和IMNM（45例）患者，记录性别、发病年龄、确诊年龄和延误就诊时间；酶耦联法测定血清肌酸激酶水平；英国医学研究理事会6级测定法评价颈屈肌、上肢近端和远端肌力、下肢近端和远端肌力并计算肌力百分比；双大腿MRI评价骨骼肌脂肪浸润和水肿程度。结果 LGMD2B型患者发病年龄（Z=-3.605，P=0.000）和确诊年龄（Z=-2.757，P=0.006）早于、就诊延误时间长于（Z=-4.749，P=0.000）、血清肌酸激酶水平高于（Z=-2.247，P=0.025）IMNM患者。IMNM患者颈屈肌肌力（Z=-6.320，P=0.000）和肌力百分比（t=-6.320，P=0.000），以及上肢近端肌力（Z=-3.528，P=0.000）和肌力百分比（t=-3.762，P=0.000）低于LGMD2B型患者，而LGMD2B型患者下肢远端肌力（Z=-3.256，P=0.001）和肌力百分比（t=-2.883，P=0.004）低于IMNM患者。LGMD2B型患者双大腿前群肌（Z=-3.119，P=0.002）和后群肌（Z=-2.534，P=0.011）脂肪浸润程度高于IMNM患者，而IMNM患者双大腿后群肌水肿程度高于LGMD2B型患者（Z=-3.887，P=0.000）。。结论与IMNM患者相比，LGMD2B型患者发病年龄更早、延误就诊时间更长、下肢远端肌力更差、血清肌酸激酶水平更高、大腿肌肉脂肪浸润程度更严重；而IMNM患者则呈现更为严重的颈屈肌和上肢近端肌无力，以及明显的大腿后群肌水肿。

关键词: 肌营养不良,肢带型, 多发性肌炎, 坏死, 自身免疫, 肌力, 肌,骨骼, 磁共振成像

Abstract:

Objective To investigate the clinical and imaging differences between limb-girdle muscular dystrophy type 2B (LGMD2B) and immune-mediated necrotizing myopathy (IMNM). Methods Forty-five patients with LGMD2B and 45 patients with IMNM from January 2014 to December 2018 were included. Sex, age of onset, age of diagnosis and time of delay in admission were recorded, and serum creatine kinase (CK) level was measured. Cervical flexion, proximal and distal upper limbs, proximal and distal lower limbs were evaluated by Medical Research Council (MRC) Level 6 and muscle strength percentages were calculated. Skeletal muscle fatty infiltration and edema degree on both thighs were evaluated by MRI. Results The onset age (Z=-3.605, P=0.000) and diagnosis age (Z=-2.757, P=0.006) of LGMD2B patients were earlier than those of IMNM patients, while the delay time of admission was longer than that of IMNM patients (Z=-4.749, P=0.000), the serum CK was higher than that of IMNM patients (Z=-2.247, P=0.025). The muscle strength of neck flexion (Z=-6.320, P=0.000) and percentage of muscle strength (t=-6.320, P=0.000), the muscle strengh of proximal upper extremities (Z=-3.528, P=0.000) and percentage of muscle strength (t=-3.762, P=0.000) in IMNM patients were lower than those in LGMD2B patients, while the muscle strengh of distal lower extremity (Z=-3.256, P=0.001) and percentage of muscle strength (t=-2.883, P=0.004) in LGMD2B patients were lower than those in IMNM patients. LGMD2B patients had higher muscle fatty infiltration degree in anterior group (Z=-3.119, P=0.002) and posterior group (Z=-2.534, P=0.011) of thigh muscle than IMNM patients, but IMNM patients had highter thigh muscle edema degree in posterior group than LGMD2B patients (Z=-3.887, P=0.000). Conclusions Compared with IMNM patients, LGMD2B patients had earlier onset age, longer delay in diagnosis time, worse muscle strength of distal lower extremities, higher serum CK and more obviously thigh muscle fatty infiltration. In IMNM patients, muscle weakness of neck flexion and proximal upper extremities, thigh muscle edema of posterior group were more obvious. These characteristics contribute to the clinical differentiation of the two diseases.

Key words: Muscular dystrophies, limb-girdle, Polymyositis, Necrosis, Autoimmunity, Muscle strength, Muscle, skeletal, Magnetic resonance imaging

赵亚雯, 王艳莉, 王朝霞, 张巍, 袁云. 肢带型肌营养不良症2B型与免疫介导的坏死性肌病临床及影像学差异分析[J]. 中国现代神经疾病杂志, 2020, 20(9): 773-778.

ZHAO Ya-wen, WANG Yan-li, WANG Zhao-xia, ZHANG Wei, YUAN Yun. Clinical and imaging differences between limb-girdle muscular dystrophy type 2B and immune-mediated necrotizing myopathy[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2020, 20(9): 773-778.

http://journal11.magtechjournal.com/cjcnn/CN/Y2020/V20/I9/773

参考文献

[1] Urtizberea JA, Bassez G, Leturcq F, Nguyen K, Krahn M, Levy N. Dysferlinopathies[J]. Neurol India, 2008, 56:289-297.
[2] Jin S, Du J, Wang Z, Zhang W, Lv H, Meng L, Xiao J, Yuan Y. Heterogeneous characteristics of MRI changes of thigh muscles in patients with dysferlinopathy[J]. Muscle Nerve, 2016, 54:1072-1079.
[3] Kassardjian CD, Lennon VA, Alfugham NB, Mahler M, Milone M. Clinical features and treatment outcomes of necrotizing autoimmune myopathy[J]. JAMA Neurol, 2015, 72:996-1003.
[4] Miller T, Al-Lozi MT, Lopate G, Pestronk A. Myopathy with antibodies to the signal recognition particle:clinical and pathologic features[J]. J Neurol Neurosurg Psychiatry, 2002, 73:420-428.
[5] Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA; 119th ENMC International Workshop. Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands[J]. Neuromuscul Disord, 2004, 14:337-345.
[6] Li Y, Fu J, Meng LC, Zhang W, Wang ZX, Lü H, Zuo YH, Yuan Y. Analysis on clinical features of necrotizing autoimmune myopathy[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2016, 16:689-695.[李毅, 付俊, 孟令超, 张巍, 王朝霞, 吕鹤, 左越焕, 袁云. 免疫性坏死性肌病临床特点分析[J]. 中国现代神经疾病杂志, 2016, 16:689-695.]
[7] Zheng Y, Liu L, Wang L, Xiao J, Wang Z, Lv H, Zhang W, Yuan Y. Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle[J]. Rheumatology (Oxford), 2015, 54:1017-1024.
[8] Jethwa H, Jacques TS, Gunny R, Wedderburn LR, Pilkington C, Manzur AY. Limb girdle muscular dystrophy type 2B masquerading as in fl ammatorymyopathy:case report[J]. Pediatr Rheumatol Online J, 2013, 11:19.
[9] Xu C, Chen J, Zhang Y, Li J. Limb-girdle muscular dystrophy type 2B misdiagnosed as polymyositis at the early stage:case report and literature review[J]. Medicine (Baltimore), 2018, 97:e10539.
[10] Scott OM, Hyde SA, Goddard C, Dubowitz V. Quantitation of muscle function in children:a prospective study in Duchenne muscular dystrophy[J]. Muscle Nerve, 1982, 5:291-301.
[11] Xie Z, Xiao J, Zheng Y, Wang Z, Yuan Y. Magnetic resonance imaging findings in the muscle tissue of patients with limb girdle muscular dystrophy type 2I harboring the founder mutation c.545A> G in the FKRP gene[J]. Biomed Res Int, 2018:ID3710814.
[12] Stramare R, Beltrame V, Dal Borgo R, Gallimberti L, Frigo AC, Pegoraro E, Angelini C, Rubaltelli L, Feltrin GP. MRI in the assessment of muscular pathology:a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies[J]. Radiol Med, 2010, 115:585-599.
[13] Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BG. Anti-signal recognition particle autoantibodies:marker of a necrotizing myopathy[J]. Ann Rheum Dis, 2006, 65:1635-1638.
[14] Petersen JA, Kuntzer T, Fischer D, von der Hagen M, Huebner A, Kana V, Lobrinus JA, Kress W, Rushing EJ, Sinnreich M, Jung HH. Dysferlinopathy in Switzerland:clinical phenotypes and potential founder effects[J]. BMC Neurol, 2015, 15:182.
[15] Winckler PB, da Silva AM, Coimbra-Neto AR, Carvalho E, Cavalcanti EB, Sobreira CF, Marrone CD, Machado-Costa MC, Carvalho AA, Feio RH, Rodrigues CL, Gonçalves MV, Tenório RB, Mendon ça RH, Cotta A, Paim JF, Costa E, Silva C, de Aquino Cruz C, Bená MI, Betancur DF, El Husny AS, de Souza IC, Duarte RC, Reed UC, Chaves ML, Zanoteli E, Franç a MC Jr, Saute JA. Clinicogenetic lessons from 370 patients with autosomal recessive limb-girdle muscular dystrophy[J]. Clin Genet, 2019, 96:341-353.
[16] Park HJ, Hong JM, Suh GI, Shin HY, Kim SM, Sunwoo IN, Suh BC, Choi YC. Heterogeneous characteristics of Korean patients with dysferlinopathy[J]. J Korean Med Sci, 2012, 27:423-429.
[17] Ellis E, Tan JA, Lester S, Tucker G, Blumbergs P, Roberts-Thomson P, Limaye V. Necrotizing myopathy:clinicoserologic associations[J]. Muscle Nerve, 2012, 45:189-194.
[18] Wang L, Liu L, Hao H, Gao F, Liu X, Wang Z, Zhang W, Lv H, Yuan Y. Myopathy with anti-signal recognition particle antibodies:clinical and histopathological features in Chinese patients[J]. Neuromuscul Disord, 2014, 24:335-341.
[19] Rouster-Stevens KA, Pachman LM. Autoantibody to signal recognition particle in African American girls with juvenile poly-myositis[J]. J Rheumatol, 2008, 35:927-929.
[20] Jin SQ, Zhang W, Lü H, Liu Q, Song SJ, Du J, Xiao JX, Wang ZX, Yuan Y. Muscle magnetic resonance imaging changes and relationship with clinical symptoms in patients with dysferlinopathy[J]. Zhonghua Shen Jing Ke Za Zhi, 2014, 47:412-417.[金苏芹,张巍, 吕鹤, 柳青, 宋书娟, 杜婧, 肖江喜, 王朝霞, 袁云. Dysferlinopathy患者大腿骨骼肌MRI改变及其临床表现的相关性[J]. 中华神经科杂志, 2014, 47:412-417.]
[21] Arrigoni F, De Luca A, Velardo D, Magri F, Gandossini S, Russo A, Froeling M, Bertoldo A, Leemans A, Bresolin N, D'angelo G. Multiparametric quantitative MRI assessment of thigh muscles in limb-girdle muscular dystrophy 2A and 2B[J]. Muscle Nerve, 2018, 58:550-558.
[22] Gómez-Andrés D, Díaz J, Munell F, Sánchez-Montáñez Á, Pulido-Valdeolivas I, Suazo L, Garrido C, Quijano-Roy S, Bevilacqua JA. Disease duration and disability in dysferlinopathy can be described by muscle imaging using heatmaps and random forests[J]. Muscle Nerve, 2019, 59:436-444.
[23] Suzuki S, Nishikawa A, Kuwana M, Nishimura H, Watanabe Y, Nakahara J, Hayashi YK, Suzuki N, Nishino I. Inflammatory myopathy with anti-signal recognition particle antibodies:case series of 100 patients[J]. Orphanet J Rare Dis, 2015, 10:61.
[24] Zhao YW, Liu XJ, Zhang W, Yuan Y. Childhood autoimmune necrotizing myopathy with anti-signal recognition particle antibodies[J]. Muscle Nerve, 2017, 56:1181-1187.
[25] Zhao YW, Liu XJ, Zhang W, Wang ZX, Yuan Y. Muscle magnetic resonance imaging for the differentiation of multiple Acyl-CoA dehydrogenase deficiency and immune-mediated necrotizing myopathy[J]. Chin Med J (Engl), 2018, 131:144-150.
[26] Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L. Thigh muscle MRI in immune-mediated necrotising myopathy:extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity[J]. Ann Rheum Dis, 2017, 76:681-687.

选择文件类型/文献管理软件名称

选择包含的内容

2 肢带型肌营养不良症2B型与免疫介导的坏死性肌病临床及影像学差异分析

Clinical and imaging differences between limb-girdle muscular dystrophy type 2B and immune-mediated necrotizing myopathy

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	马晓丽, 童家杰, 张秀智, 杜倩, 隋爱霞, 赵焕芬. 表现为垂体腺瘤卒中的黄色瘤性垂体炎[J]. 中国现代神经疾病杂志, 2023, 23(7): 599-603.
[2]	潘希娟, 邢英琦, 刘玉梅. 脑小血管病影像学评分方法[J]. 中国现代神经疾病杂志, 2023, 23(7): 633-637.
[3]	邵暇荔, 张泳, 金莉蓉, 王剑. 震颤为主型帕金森病与特发性震颤患者脑灌注对比分析[J]. 中国现代神经疾病杂志, 2023, 23(6): 542-548.
[4]	刘智强, 陈金桃, 唐文龙, 翁超群, 张金锋, 林志雄. Dandy-Walker综合征患儿腹腔分流术前后临床与影像学特征分析[J]. 中国现代神经疾病杂志, 2023, 23(5): 433-438.
[5]	姚莉萍, 王睿晗, 包翌, 蔡瀚林, 陈芹. 后部皮质萎缩临床及影像学特征分析[J]. 中国现代神经疾病杂志, 2023, 23(4): 326-334.
[6]	葛懿, 陈聪, 王爽, 丁瑶. 7T超高场强MRI在耐药性癫痫诊断与治疗中的应用进展[J]. 中国现代神经疾病杂志, 2023, 23(3): 161-166.
[7]	耿雨梅, 李存, 李慧敏, 王梦莹, 康慧聪. 伴癫痫发作的自身免疫性脑炎临床特征分析[J]. 中国现代神经疾病杂志, 2023, 23(3): 205-213.
[8]	李承玉, 王圣松, 陈超, 史伟雄, 王群, 邵晓秋. 抗富亮氨酸胶质瘤失活蛋白1抗体相关脑炎症状性发作临床与脑电图特征[J]. 中国现代神经疾病杂志, 2023, 23(3): 214-222.
[9]	李建瑞, 刘宵雪, 许强, 骆仲强, 卢光明, 张志强. 扩散峰度成像直方图联合EphA2分级在胶质瘤分级诊断中的价值[J]. 中国现代神经疾病杂志, 2023, 23(3): 254-263.
[10]	任瑞青, 沈恺源, 丁晶, 汪昕. 自身免疫相关性癫痫临床研究进展[J]. 中国现代神经疾病杂志, 2023, 23(2): 94-99.
[11]	孙梦凡, 姜季委, 王艳丽, 张源, 徐俊. 动脉自旋标记测定脑血流量在阿尔茨海默病研究中的进展[J]. 中国现代神经疾病杂志, 2023, 23(1): 29-34.
[12]	于宁波, 游煜根, 王鸿鹏, 秦岩丁, 梁思泉, 韩建达. 机器人辅助神经介入手术研究进展[J]. 中国现代神经疾病杂志, 2023, 23(1): 45-52.
[13]	姜季委, 张巍, 陈启东, 张贵丽, 李汶逸, 徐俊. 表现为孤立性皮质病变的抗髓鞘少突胶质细胞糖蛋白免疫球蛋白G抗体相关疾病合并桥本甲状腺炎和干燥综合征一例[J]. 中国现代神经疾病杂志, 2022, 22(9): 777-782.
[14]	李佩湖, 封浑, 李吕力, 姜炳坚. 以脑卒中样发病的可逆性胼胝体压部病变综合征Ⅱ型二例[J]. 中国现代神经疾病杂志, 2022, 22(9): 817-822.
[15]	姚庆宇, 马龙冰, 菅凤增. 脊髓空洞症大鼠模型长期稳定性评价[J]. 中国现代神经疾病杂志, 2022, 22(8): 662-668.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 肢带型肌营养不良症2B型与免疫介导的坏死性肌病临床及影像学差异分析

Clinical and imaging differences between limb-girdle muscular dystrophy type 2B and immune-mediated necrotizing myopathy

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价